Wnt5a expression and prognosis in stage II–III colon cancer

The WNT5A Agonist Foxy5 Reduces the Number of Colonic Cancer Stem Cells in a Xenograft Mouse Model of Human Colonic Cancer

(2019) JANINA OSMAN et al.   ANTICANCER RESEARCH

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2018) Freddie Bray et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Recurrence Risk After Up-to-Date Colon Cancer Staging, Surgery, and Pathology

(2018) Erik Osterman et al.   DISEASES OF THE COLON & RECTUM

Non-canonical WNT5A signaling up-regulates the expression of the tumor suppressor 15-PGDH and induces differentiation of colon cancer cells

(2016) Lubna M. Mehdawi et al.   Molecular Oncology

Disease-free survival after complete mesocolic excision compared with conventional colon cancer surgery: a retrospective, population-based study

(2015) Claus Anders Bertelsen et al.   LANCET ONCOLOGY

Emphasizing the role of Wnt5a protein expression to predict favorable outcome after radical prostatectomy in patients with low-grade prostate cancer

(2012) Azharuddin Sajid Syed Khaja et al.   Cancer Medicine

Wnt5a Suppresses Epithelial Ovarian Cancer by Promoting Cellular Senescence

(2011) B. G. Bitler et al.   CANCER RESEARCH

Initial steps of metastasis: Cell invasion and endothelial transmigration

(2011) Franziska van Zijl et al.   MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH

Elevated Level of Wnt5a Protein in Localized Prostate Cancer Tissue Is Associated with Better Outcome

(2011) Azharuddin Sajid Syed Khaja et al.   PLoS One

WNT5A Exhibits Tumor-Suppressive Activity through Antagonizing the Wnt/ -Catenin Signaling, and Is Frequently Methylated in Colorectal Cancer

(2008) J. Ying et al.   CLINICAL CANCER RESEARCH